Skip to main content

WBA

Stock
Health Care
Pharmaceutical Retailers

Performance overview

WBA Price
Price Chart

Forward-looking statistics

Beta
1.42
Risk
68.14%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Company info

SectorHealth Care
IndustryPharmaceutical Retailers
Employees171K
Market cap$13.7B

Fundamentals

Enterprise value$39.2B
Revenue$154.6B
Revenue per employee—
Profit margin-4.07%
Debt to equity409.88

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$7.29
Dividend per share$1.00
Revenue per share$178.88
Avg trading volume (30 day)$109M
Avg trading volume (10 day)$99M
Put-call ratio—

Macro factor sensitivity

Growth+0.2
Credit+4.5
Liquidity+0.2
Inflation-3.3
Commodities-0.8
Interest Rates-0.7

Valuation

Dividend yield8.68%
PEG Ratio7.80
Price to sales0.06
P/E Ratio7.80
Enterprise Value to Revenue0.25
Price to book1.38

Upcoming events

Next earnings dayApril 8, 2025
Next dividend day—
Ex. dividend dayNovember 18, 2024

News

Walgreens Takes Major Step Toward Becoming Private Company Again

Walgreens Boots Alliance Inc. has taken a major step forward in its bid to go private after it announced that at the Company's Special Meeting of Shareholders, WBA shareholders had approved the previously announced acquisition of the company by entities affiliated with Sycamore Partners Management.

Forbes (July 14, 2025)
Walgreens Shareholders Approve $10 Billion Private Equity Buyout

Walgreens Boots Alliance shareholders Friday approved private equity firm Sycamore Partners' $10 billion buyout offer for the iconic drugstore chain.

Forbes (July 11, 2025)
Crude Oil Gains Over 1%; Walgreens Posts Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.

Benzinga (June 26, 2025)
Cramer's Stop Trading: Walgreens Boots

CNBC's Jim Cramer breaks down why he's keeping an eye on shares of Walgreens.

CNBC Television (June 26, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free